UBS O'Connor’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-49,000
Closed -$497K 444
2025
Q2
$497K Buy
49,000
+1,358
+3% +$9.12K 0.01% 272
2025
Q1
$266K Sell
47,642
-127,204
-73% -$1.11M 0.01% 243
2024
Q4
$1.41M Buy
174,846
+31,526
+22% +$289K 0.04% 202
2024
Q3
$1.47M Buy
143,320
+28,954
+25% +$286K 0.04% 225
2024
Q2
$809K Buy
114,366
+22,000
+24% +$197K 0.02% 326
2024
Q1
$1.27M Sell
92,366
-170,590
-65% -$2.03M 0.04% 248
2023
Q4
$2.42M Sell
262,956
-88,546
-25% -$640K 0.08% 150
2023
Q3
$2.13M Sell
351,502
-10,000
-3% -$81.9K 0.04% 237
2023
Q2
$2.81M Sell
361,502
-1,205
-0.3% -$6.84K 0.06% 207
2023
Q1
$2.07M Buy
+362,707
New +$1.9M 0.05% 307
2022
Q4
Sell
-343,002
Closed -$1.1M 249
2022
Q3
$1.1M Sell
343,002
-18,053
-5% -$72.3K 0.01% 735
2022
Q2
$1.62M Buy
+361,055
New +$1.44M 0.02% 694

Other funds holding ORIC